Loading clinical trials...
Loading clinical trials...
A Phase 2B/3 Open-label Trial of VTS-270 (2-hydroxypropyl-β-cyclodextrin) in Subjects With Neurologic Manifestations of Niemann-Pick Type C1 Disease Previously Treated Under Protocol VTS301
Conditions
Interventions
VTS-270
Locations
1
Costa Rica
Hospital Clinica Biblica
San José, Costa Rica
Start Date
December 2, 2019
Primary Completion Date
October 18, 2021
Completion Date
October 18, 2021
Last Updated
December 26, 2023
NCT04958642
NCT01306604
NCT03887533
NCT02939547
NCT00975689
Lead Sponsor
Mandos LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions